A critical advance in cancer study is arising with the use of VHH fragments to reactivate dysfunctional p53. This essential cancer suppressor protein is frequently disabled in various types of tumors, leading https://maroonbookmarks.com/story21871977/mini-antibodies-restore-tumor-suppressor-p53-new-promising-pathway-for-tumor-treatment